B Castro1, F D Bastida2, T Segovia3, P López Casanova4, J J Soldevilla5, J Verdú-Soriano6. 1. PhD Chief Scientist Officer, Histocell S.L., Bizkaia Science and Technology Park, Derio, Bizkaia (Spain). 2. Senior Scientist-Wound Care, Histocell S.L., Bizkaia Science and Technology Park, Derio, Bizkaia (Spain). 3. Supervisor, Multidisciplinary Chronic Wounds Unit, Executive Member of Spanish Pressure Ulcers and Chronic Wounds Advisory Panel, University Hospital Puerta del Hierro, Majadahonda, Madrid (Spain). 4. PhD Community Health Nurse, Health Department of Alcoy, Alicante (Spain). 5. Professor, Nursing School, University of La Rioja, Logroño (Spain); Hospital de San Pedro, Servicio Riojano de Salud, La Rioja, (Spain); Head of Spanish Pressure Ulcers and Chronic Wounds Advisory Panel. 6. Professor, Histocell S.L., Bizkaia Science and Technology Park, Derio, Bizkaia (Spain).
Abstract
OBJECTIVE: Oxidative stress can contribute to impaired wound healing and chronic wounds. Our objective was to test the results of a new antioxidant dressing that could help stop the oxidative stress of cells in the wound bed. METHOD: A multicentre, prospective case study series was conducted in three Spanish hospitals. The RESVECH 2.0 index was used for healing assessment. Data from each patient was collected by the attending clinical researchers. Data analysis was performed using the statistical concept intention-to-treat (ITT). Descriptive results were presented as frequency and percentages for qualitative variables and mean, standard deviation (SD), range and median for quantitative variables. For analytical-inferential analyses, incidence of healing was calculated for chronic and acute wounds. Relative risk (RR) was used to establish the differences of healing between both types of wounds. Healing was represented by Kaplan-Meier survival curves, and these were compared using the log-rank test. RESULTS: A total of 31 patients with hard-to-heal wounds were recruited. During the 8-week follow-up period, nine wounds (29%) completely healed, of which seven (77.8%) were acute and two (22.2%) chronic. The remaining wounds (22) showed a significant improvement after treatment with the antioxidant dressing. RESVECH 2.0 scores decreased an average of 10.16 points over the 8-week period. CONCLUSION: The antioxidant dressing could represent an alternative in the dressing landscape for many types of acute and chronic wounds.
OBJECTIVE: Oxidative stress can contribute to impaired wound healing and chronic wounds. Our objective was to test the results of a new antioxidant dressing that could help stop the oxidative stress of cells in the wound bed. METHOD: A multicentre, prospective case study series was conducted in three Spanish hospitals. The RESVECH 2.0 index was used for healing assessment. Data from each patient was collected by the attending clinical researchers. Data analysis was performed using the statistical concept intention-to-treat (ITT). Descriptive results were presented as frequency and percentages for qualitative variables and mean, standard deviation (SD), range and median for quantitative variables. For analytical-inferential analyses, incidence of healing was calculated for chronic and acute wounds. Relative risk (RR) was used to establish the differences of healing between both types of wounds. Healing was represented by Kaplan-Meier survival curves, and these were compared using the log-rank test. RESULTS: A total of 31 patients with hard-to-heal wounds were recruited. During the 8-week follow-up period, nine wounds (29%) completely healed, of which seven (77.8%) were acute and two (22.2%) chronic. The remaining wounds (22) showed a significant improvement after treatment with the antioxidant dressing. RESVECH 2.0 scores decreased an average of 10.16 points over the 8-week period. CONCLUSION: The antioxidant dressing could represent an alternative in the dressing landscape for many types of acute and chronic wounds.
Authors: Antonio Casado-Diaz; José Manuel Moreno-Rojas; José Verdú-Soriano; José Luis Lázaro-Martínez; Leocadio Rodríguez-Mañas; Isaac Tunez; Manuel La Torre; Miriam Berenguer Pérez; Feliciano Priego-Capote; Gema Pereira-Caro Journal: Pharmaceutics Date: 2022-02-01 Impact factor: 6.321
Authors: José Verdú-Soriano; Marisol de Cristino-Espinar; Silvia Luna-Morales; Caridad Dios-Guerra; Javier Caballero-Villarraso; Paloma Moreno-Moreno; Antonio Casado-Díaz; Miriam Berenguer-Pérez; Ipek Guler-Caamaño; Olga Laosa-Zafra; Leocadio Rodríguez-Mañas; José Luis Lázaro-Martínez Journal: J Clin Med Date: 2022-02-25 Impact factor: 4.241
Authors: Inés María Comino-Sanz; María Dolores López-Franco; Begoña Castro; Pedro Luis Pancorbo-Hidalgo Journal: Trials Date: 2020-06-08 Impact factor: 2.279